Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[midastouch017]

Kitov Pharma +18% on new European patent for anti-CEACAM1 antibody

Jul. 8, 2020 8:05 AM ET|About: Kitov Pharma Ltd (KTOV)|By: Mamta Mayani, SA News Editor

The European Patent Office intends to grant a new patent to Kitov Pharma (NASDAQ:KTOV) for application entitled “Humanized antibodies against CEACAM1.”

The patent covers protein and DNA sequences pertaining to humanized antibodies capable of specific binding to human CEACAM1 molecules, including monoclonal antibody, CM24, pharmaceutical compositions comprising these antibodies, as well as methods for their use in treating and diagnosing cancer and other conditions.

Shares are up 18% premarket.

https://seekingalpha.com/news/3589414-kitov-pharmaplus-18-on-new-european-patent-for-anti-ceacam1-antibody?utm_medium=email&utm_source=seeking_alpha&mail_subject=ktov-kitov-pharma-18-on-new-european-patent-for-anti-ceacam1-antibody&utm_campaign=rta-stock-news&utm_content=link-1